FDA Inspection 1229726 — BOMAZ, INC.

BOMAZ, INC. — FEI 3000210418

The FDA completed an inspection of BOMAZ, INC. on Feb 14, 2024 in Hammond, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 14, 2024
Fiscal Year
2024
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Hammond, WI (United States)

Citations

IDCFRDescription
22694FDCA 402(a)(2)(C)(ii)Introduction/delivery into IS - illegal drug residue
4185FDCA 402(a)(4)Record keeping

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.